| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84f08b6b15cd8517193a2a54526877da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d29c20b02a277b1f645deb73083d49a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6315eb811d786f256d70bac9086b3aa8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43527 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
1998-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d1ff533e49b546e1e55f9920ac310d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3731c7b9f6d230505e08201aa8c49467 |
| publicationDate |
1999-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9927104-A1 |
| titleOfInvention |
Histamine and serotonin binding molecules |
| abstract |
The present invention relates to histamine and serotonin binding molecules that possess a binding site with the precise molecular configuration that is necessary to confer on the molecule a high affinity for histamine. The invention includes proteins, peptides and chemical compounds that possess this molecular configuration and that are thus able to bind to histamine with high affinity. These molecules may be used in the regulation of the action of histamine or serotonin, the detection and quantification or histamine or serotonin and in the treatment of various diseases and allergies. The molecules may also be used as components of vaccines directed against blood-sucking ectoparasites. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004226697-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019110825-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6737399-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737445-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10070639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-778514-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0115719-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0116164-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-780773-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9226489-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6794360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013226-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0115719-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0116164-A3 |
| priorityDate |
1997-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |